Form SCHEDULE 13G/A Ascendis Pharma A/S Filed by: FMR LLC
Filed on: November 5, 20
Related stories
US session market picture: S&P 500 +0.22%, Nasdaq 100 +0.23%; EUR/USD -0.26%, WTI +0.99%, NVDA leads volume
US session market picture. US index futures: S and P futures is up 0.22 percent, Nasdaq futures is up 0.23 percent, Dow futures is up 0.29 percent and Russell futures is down 0.74
M impact | EQUITY | Nov 12, 2026, 05:00 PM UTC
SpaceX Plans More Than $74 Billion for Data Centers in Texas and Arizona
SpaceX plans to invest more than $74 billion across two supercomputing facilities. It said Thursday it plans to spend around $24 billion on a data center in Texas’s Rio Grande Vall
M impact | EQUITY | Nov 12, 2026, 04:58 PM UTC
Exus Renewables North America Secures $345 Million Financing
Goldman Sachs Alternatives led the financing. Capital will support construction and new project development across Exus' U.S. renewable energy portfolio.
M impact | EQUITY | Nov 12, 2026, 04:55 PM UTC
Coca-Cola Shares Tick to New All-Time High, Up 0.5%
Coca-Cola shares are up over 40% year to date.
M impact | EQUITY | Nov 12, 2026, 04:52 PM UTC
SpaceX Plans More Than $74 Billion in AI Sites in Texas and Arizona
M impact | EQUITY | Nov 12, 2026, 04:48 PM UTC
Corteva Says Brazil Market Conditions Deteriorated Sharply in Q3’s Final Weeks
Corteva said the negative trend continues.
M impact | EQUITY | Nov 12, 2026, 04:47 PM UTC